Mytrex Health Technologies, Inc. (TPEX:4431)
Taiwan · Delayed Price · Currency is TWD 18.60
-0.20 (-1.06%)
At close: Feb 11, 2026
TPEX:4431 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -83.3 | -82.38 | -56.22 | -91.9 | -14.01 | 352.27 |
Depreciation & Amortization | 79.73 | 89.71 | 91.29 | 102.48 | 50.6 | 27.46 |
Other Amortization | 4.61 | 5.76 | 5.7 | 4.03 | - | - |
Loss (Gain) From Sale of Assets | 0.4 | -17.51 | 4.1 | -8.68 | 0.16 | -0.15 |
Asset Writedown & Restructuring Costs | 41.24 | 41.65 | -0.92 | 51.47 | 25.65 | - |
Loss (Gain) From Sale of Investments | - | - | - | - | -33.34 | -6.41 |
Loss (Gain) on Equity Investments | -0.75 | 0.26 | -0.94 | -1.66 | 0.86 | 0.4 |
Stock-Based Compensation | - | - | - | - | -2.9 | 31.22 |
Provision & Write-off of Bad Debts | 8.55 | 0.68 | 1.27 | -0.12 | -0.02 | 1.76 |
Other Operating Activities | -5.98 | -6.29 | -8.19 | 17.99 | -74.51 | 89.14 |
Change in Accounts Receivable | 20.25 | 23.52 | -55.78 | 18.52 | 45.13 | -27.05 |
Change in Inventory | -7.4 | 2.26 | -18.64 | 3.47 | 41.96 | -62.6 |
Change in Accounts Payable | -55.62 | 53.61 | 71 | -8.42 | -3.4 | -5.27 |
Change in Unearned Revenue | 2.51 | -1.33 | 1.05 | -1.27 | -2.43 | 2.55 |
Change in Other Net Operating Assets | -4.36 | -78.31 | -37.97 | -13.43 | -20.47 | 37.43 |
Operating Cash Flow | -0.11 | 31.63 | -4.26 | 72.48 | 13.29 | 440.76 |
Operating Cash Flow Growth | - | - | - | 445.52% | -96.99% | 635.68% |
Capital Expenditures | -3.9 | -8.88 | -21.77 | -35.5 | -29.75 | -188 |
Sale of Property, Plant & Equipment | 0.05 | 49.9 | 2.38 | 9.59 | 2.4 | 0.39 |
Cash Acquisitions | - | - | -230 | - | - | - |
Divestitures | - | - | - | - | - | 0.35 |
Sale (Purchase) of Intangibles | -5.2 | -6.16 | -3.24 | -7.81 | -0.59 | -1.26 |
Investment in Securities | - | - | - | -52.24 | 12.81 | -1 |
Other Investing Activities | -47.68 | 28.51 | -15.66 | -1.95 | -15.95 | -8.84 |
Investing Cash Flow | -56.73 | 63.36 | -268.29 | -87.91 | -31.07 | -198.36 |
Short-Term Debt Issued | - | 3.62 | 44.21 | 12.52 | - | 88.06 |
Long-Term Debt Issued | - | 2.55 | 116.3 | - | - | - |
Total Debt Issued | -8.55 | 6.17 | 160.51 | 12.52 | - | 88.06 |
Short-Term Debt Repaid | - | - | - | - | -109.03 | - |
Long-Term Debt Repaid | - | -51.59 | -155.36 | -55.54 | -10.46 | -4.84 |
Total Debt Repaid | -52.22 | -51.59 | -155.36 | -55.54 | -119.5 | -4.84 |
Net Debt Issued (Repaid) | -60.77 | -45.42 | 5.15 | -43.02 | -119.5 | 83.22 |
Issuance of Common Stock | - | - | - | - | - | 264 |
Common Dividends Paid | - | - | - | - | -121.79 | -4.13 |
Other Financing Activities | 3.67 | 5.04 | 0.26 | -16.82 | - | 2.69 |
Financing Cash Flow | -57.1 | -40.38 | 5.41 | -59.84 | -241.28 | 345.78 |
Foreign Exchange Rate Adjustments | -2.04 | 1.75 | -0.74 | 2.08 | -5.02 | -3.1 |
Net Cash Flow | -115.98 | 56.36 | -267.87 | -73.2 | -264.08 | 585.08 |
Free Cash Flow | -4.02 | 22.75 | -26.03 | 36.98 | -16.46 | 252.76 |
Free Cash Flow Growth | - | - | - | - | - | 403.00% |
Free Cash Flow Margin | -0.21% | 1.29% | -2.01% | 2.51% | -5.64% | 24.69% |
Free Cash Flow Per Share | -0.11 | 0.62 | -0.71 | 1.01 | -0.45 | 7.68 |
Cash Interest Paid | 5.82 | 6.16 | 6.34 | 5.24 | 1.66 | 1.33 |
Cash Income Tax Paid | 2.2 | 3.39 | 7.48 | 11.02 | 79.49 | 0.29 |
Levered Free Cash Flow | -3.19 | 27.06 | -18.41 | 17.75 | -5.09 | 176.04 |
Unlevered Free Cash Flow | 0.47 | 30.89 | -14.53 | 21 | -4.11 | 176.87 |
Change in Working Capital | -44.61 | -0.26 | -40.34 | -1.13 | 60.79 | -54.93 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.